Harbour BioMed and Dana-Farber Cancer Institute to codevelop novel biotherapies for cancer June 16, 2021 No Comments
FDA authorizes phase Ib/II study of Anktiva plus chemoimmunotherapy in TNBC June 16, 2021 No Comments
IL1RAP is a key driver of metastasis and a potential immunotherapy target in Ewing sarcoma June 15, 2021 No Comments
Inceptor Bio uses seed funding to advance next-generation cell therapy platforms for cancer June 14, 2021 No Comments
RSS